Nutritional prediction in the clinical course of patients with acute chronic obstructive lung disease
Keywords:
malnutrition, chronic obstructive lung disease, prediction, unfavorable clinical courseAbstract
Introduction: The maintenance of an appropriate nutritional state is fundamental in people with respiratory diseases, since malnutrition can cause negative effects in the respiratory system and affect its musculature, the lung parenchyma, as well as the immune system.
Objective: To determine the prediction charge of the nutritional state when admitted to the institution and the artificial mechanical ventilation on the unfavorable clinical course of patients with acute chronic obstructive lung disease.
Methods: A descriptive, applied and explanatory study was carried out on 39 patients with acute chronic obstructive lung disease, who were admitted to the Intensive and Intermediate Care Service of Saturnino Lora Torres Teaching Clinical-Surgical Provincial Hospital in Santiago de Cuba, from October, 2022 to November, 2023.
Results: There was a prevalence of the 65 and over age group (64.1 %); on his arrival at the service, 24.1 % of the patients presented altered albumin, 56,4 % was undernourished and invasive mechanical artificial ventilation prevailed (53.8 %). The deficiency malnutrition on admission constituted a significant causal factor (p = 0.029) with unfavorable clinical course in those affected and exposed to this risk [OR = 6.22; I.C 95%: 1.21; 32.02].
Conclusions: This study indicated that malnutrition on admission of the patients with acute chronic obstructive lung disease constitutes a prediction factor of unfavorable clinical course.
Downloads
References
2. Prediletto I, Giancotti G, Nava S. COPD Exacerbation: Why It Is Important to Avoid ICU Admission. J. Clin. Med. 2023 [citado 20/8/2023]; 12(10):3369. Disponible en: https://www.mdpi.com/2077-0383/12/10/3369/pdf?version=1684223466
3. Celli BR, Singh D, Vogelmeier C, Agusti A. New Perspectives on Chronic Obstructive Pulmonary Disease. Int. J. Chron. Obstruct. Pulmon. 2022 [citado 24/11/2023];17: 2127-36. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464005/pdf/copd-17-2127.pdf
4. Rodríguez Hernández Y, Sosa Remón A, Ortiz Hernández L, Matos Lastre EA, Jeréz Álvarez AE. Factores asociados al estado nutricional de pacientes con ventilación mecánica artificial en unidad de cuidados intensivos. Rev. méd. electrón. 2020 [citado 20/12/2023];42(5):e3517. Disponible en: http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/3517/4911
5. Weinreich UM, Juhl KS, Søby Christophersen M, Gundestrup S, Hanifa MA, Jensen K, et al. The Danish respiratory society guideline for long-term high flow nasal cannula treatment, with or without supplementary oxygen. Eur. Clin. Respir. J. 2023 [citado 20/12/2023];10(1):2178600. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970213/pdf/ZECR_10_2178600.pdf
6. Gutiérrez Villegas C, Paz Zulueta M, Herrero Montes M, Parás Bravo P, Madrazo Pérez M. Cost analysis of chronic obstructive pulmonary disease (COPD): A systematic review. Health Econ. Rev. 2021[citado12/01/2024];11(31):1-12. Disponible en: https://web.archive.org/web/20210818203907id_/https://healtheconomicsreview.biomedcentral.com/track/pdf/10.1186/s13561-021-00329-9.pdf
7. Álvarez A, Amorin E, Crida J, Curto A, Da Luz L, Pérez L. EPOC y riesgo nutricional en pacientes internados en el Hospital Saint Bois 2019. Montevideo-Uruguay: Centro hospitalario del Norte. Gustavo Saints Bois; 2019[citado12/01/2024]. Disponible en: https://www.colibri.udelar.edu.uy/jspui/bitstream/20.500.12008/33909/1/MCII_2019_G83.pdf
8. Pérez de Llano L, Miravitlles M, Golpe R, Álvarez-Gutiérrez FJ, Cisneros C, Almonacid C, et al. A Proposed Approach to Chronic Airway Disease (CAD) Using Therapeutic Goals and Treatable Traits: A Look to the Future. Int j chron obstruct pulmon dis. 2020[citado 24/01/2024];15:2091–100. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481271/pdf/copd-15-2091.pdf
9. Nici L, Mammen MJ, Charbek E, Alexander PE, Au DH, Boyd CM, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease An Official American Thoracic Society Clinical Practice Guideline. Am. j . respir crit. care. med. 2020[citado 25/02/2024];201:e56–69. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193862/pdf/rccm.202003-0625ST.pdf
10. Stolz D, Miravitlles M. The right treatment for the right patient with COPD: lessons from the IMPACT trial. Eur.respir.j. 2020[citado 26/03/2024]; 55:2000881. Disponible en: https://erj.ersjournals.com/content/55/5/2000881
11. Ojeda -Ibáñez MF, Vera Talledo MI. Nutrición en el paciente con enfermedad pulmonar obstructiva crónica (EPOC). Rev. soc. peru .med. interna. 2022 [citado20/12/2023];35(4):104-8.Disponible en: https://revistamedicinainterna.net/index.php/spmi/article/view/689/772
12. Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for Diagnosis, Management and Prevention of COPD. Report; 2021[citado 20/12/2023]. Disponible en: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.0-11Nov20_WMV.pdf
13. Shen X, Qian R, Wei Y , Tang Z , Zhong H , Huang J, et al. Prediction model and assessment of malnutrition in patients with stable chronic obstructive pulmonary disease. Scientifc Reports. 2024[citado2/02/2024];14:6508. Disponible en: https://www.nature.com/articles/s41598-024-56747-2.pdf
14. Fernandes AC, Bezerra OMPA. Nutrition therapy for chronic obstructive pulmonary disease and related nutritional complications. J. bras. pneumol. 2021[citado 02/02/2024];32(5):461-71. Disponible en: https://www.scielo.br/j/jbpneu/a/KqwBHQ6vGbV3DrbdxQDghgb/?lang=en&format=pdf
15. Baldemir R, Cırık MÖ. Practical parameters that can be used for nutritional assessment in patients hospitalized in the intensive care unit with the diagnosis of chronic obstructive pulmonary disease: prognostic nutritional index, neutrophil-to-lymphocyte, platelet-to-lymphocyte, and lymphocyte-to-monocyte ratio. Medicine 2022[citado2/02/2024];101(24):e29433. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276300/pdf/medi-101-e29433.pdf
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
